Overview

Phase II, Randomized, Placebo-Controlled Study of ATI-7505 in Patients With Chronic Idiopathic Constipation

Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ATI-7505 is effective in the treatment of chronic idiopathic constipation.
Phase:
Phase 2
Details
Lead Sponsor:
Procter and Gamble
Treatments:
ATI 7505